USPTO serial 79192641
AOP ORPHAN FOCUS ON RARE DISEASES
Reviewed by CopyMark Law Group
Reg. 5225397Status 709
- Filing date
- Status date
- Registration date
- Jun 20, 2017
- Examiner
- SHANOSKI, JOANNA MARIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AOP ORPHAN FOCUS ON RARE DISEASES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael Fedrick
Michael Fedrick Loza & Loza, LLP305 N. Second Ave. #127Upland, CA 91786-6064UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medical preparations for the treatment of hematology, oncology, cardiology, neurology, psychiatry, metabolic diseases and genetic disorders; sanitary preparations for medical purposes | SECTION 71 - CANCELLED | — |
| 035 | Advertising, marketing and promotional consultancy in the field of medication | SECTION 71 - CANCELLED | — |
| 039 | Distribution services, namely delivery of medications | SECTION 71 - CANCELLED | — |
| 042 | Medical and pharmaceutical research and development in the field of hematology, oncology, cardiology, neurology, psychiatry, metabolic diseases and genetic disorders; scientific research and development services in the field of hematology, oncology, cardiology, neurology, psychiatry, metabolic diseases and genetic disorders; industrial research in the field of hematology, oncology, cardiology, neurology, psychiatry, metabolic diseases and genetic disorders; professional consultancy services in the fields of medical and pharmaceutical research and development; contract research services in the field of hematology, oncology, cardiology, neurology, psychiatry, metabolic diseases and genetic disorders; computer programming | SECTION 71 - CANCELLED | — |
| 044 | Medical advisory and assistance services in the field of medication | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by AOP Orphan Pharmaceuticals AG
- Other trademarks owned by AOP Orphan Pharmaceuticals AG
- Other trademarks owned by AOP Orphan Pharmaceuticals GmbH
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AOP ORPHAN FOCUS ON RARE DISEASES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 29, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 11, 2024 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 11, 2024 | INPC | INVALIDATION PROCESSED | — |
| Sep 6, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 5, 2024 | C71T | CANCELLED SECTION 71 | — |
| Jun 20, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 18, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 26, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 28, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 22, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 22, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 20, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 20, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 4, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 4, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 1, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 15, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 15, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 15, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 28, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 28, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 27, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 27, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 25, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 4, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 4, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 16, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 15, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 15, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 11, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 5, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 5, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 1, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |